Bacterin International, Inc. Announces First Quarter 2013 Revenue of $8.6 Million

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today reported its financial results for the first quarter ended March 31, 2013. The Company reported revenues of $8.6 million and a net loss for the first quarter of approximately $1.7 million, or ($0.04) per common share, compared to a net loss of approximately $1.0 million, or ($0.03) per common share, reported during the same period in 2012.

Help employers find you! Check out all the jobs and post your resume.

Back to news